Pharmacovigilance explores the transformative potential of social media in enhancing drug safety monitoring. Traditional methods, while foundational, are limited by delayed data collection and analysis, creating gaps in timely adverse drug event detection. This review advances the field by examining the latest methodologies, including natural language processing and machine learning that enable the extraction of meaningful information from unstructured social media data. These advanced techniques provide tools to overcome challenges such as data variability and bias, making social media a viable complement to established pharmacovigilance practices. The insight from this review impacts the field by demonstrating how social media can fill critical gaps in real-time adverse drug event detection and provide a broader understanding of public sentiment and patient experiences. By emphasizing the need for interdisciplinary collaboration, ethical principles, and transparency, this review lays the foundation for a more agile, inclusive, and effective pharmacovigilance system, ultimately enhancing public health outcomes.

Pharmacovigilance is an essential component of healthcare, focused on safeguarding patients by vigilantly monitoring and managing the risks associated with medications. Traditional pharmacovigilance methods, such as spontaneous reporting systems and clinical trial data analysis, have played pivotal roles in detecting and preventing adverse drug events. However, these methods have limitations, including delayed access to critical information due to the lag between data collection and availability. This lag impedes the timely monitoring of medication safety, thereby posing challenges to real-time surveillance.

The advent of social media has introduced a new paradigm in pharmacovigilance, providing a platform for individuals to share their experiences and opinions about medications. Platforms like X (former name Twitter) and Facebook serve as repositories of user-generated content, which offer discernment into medication usage patterns, adverse drug events, and public sentiment surrounding pharmaceuticals. Such a reservoir of data can complement traditional data sources by providing near real-time information on medication safety concerns.

Despite its potential, relying solely on social media data for pharmacovigilance has challenges. A significant issue arises from the unstructured nature of social media content, which can introduce variability and noise into the data, thereby complicating the identification of drug safety signals. Furthermore, social media users may not represent the entire population, leading to potential biases in demographic representation and geographic coverage.

To overcome these challenges, advanced analytical techniques such as natural language processing and machine learning are being employed to analyze social media data more effectively. These methods enable the identification of patterns and trends, thereby assisting in the early detection of potential safety concerns and facilitating real-time monitoring of medication safety. It is crucial to ensure the reliability of social media data by validating findings with conventional data sources and maintaining strict privacy and ethical standards in data usage.

The use of social media data in pharmacovigilance represents a promising strategy for enhancing medication safety monitoring. By addressing the accompanying challenges and employing rigorous methodologies, social media data can serve as a valuable complement to conventional surveillance data. In the future, prioritizing ethical principles, promoting transparency, and fostering interdisciplinary collaboration will prove indispensable in fully harnessing the potential of social media data in safeguarding public health.

Social media platforms have emerged as significant sources of real-time data, where users freely share their experiences and opinions on various topics, including healthcare and medication usage. These platforms enable the collection of patient-reported outcomes, capture discussions on medication usage and safety, and identify the dissemination of misinformation related to drugs and vaccines. Leveraging the capabilities of these platforms empowers researchers and healthcare professionals to delve into the experiences, attitudes, and concerns of the public. This wealth of user-generated content provides a unique perspective on drug safety and efficacy, offering insight that complements traditional pharmacovigilance methods and enhancing our understanding of medication impact in real-world settings.

The use of these platforms addresses a multitude of research questions, spanning from understanding the reasons behind medication changes to evaluating public sentiments towards pharmacovigilance endeavors, and even combating the spread of health-related misinformation. This review examines the current literature on the use of social media data for drug safety analysis, with a focus on the platforms utilized, the key information extracted, the research questions addressed, and the methodologies applied. Additionally, the review discusses the challenges, limitations, and future directions of utilizing social media data for drug safety analysis.

Figure 1 provides an overview of the process for analyzing social media data to support pharmacovigilance. The process starts with data collection from various sources, including general social media platforms (e.g., X, Facebook, Instagram, Reddit, and YouTube), health-specific forums (such as WebMD and other medical forums), Q&A sites (such as Quora and Ask a Patient), and other online content (like Amazon reviews, blogs, news sites, and surveys). The information extracted from these sources is categorized primarily into Patient Experience and Perceptions and Adverse Drug Events. The extracted data undergoes further analysis in four areas:

1. Machine Learning methods for Adverse Drug Event Detection: This involves identifying and categorizing adverse drug events through methods such as supervised, semi-supervised, and unsupervised learning.

Through these stages the process integrates various machine learning and analysis techniques to draw meaningful information that can enhance pharmacovigilance practices by capturing real-world patient experiences, monitoring safety signals, and improving our understanding of drug-related issues.

Social media platforms provide diverse online environments for sharing user-generated content which contains data useful for drug safety research. General platforms like X, ¹ Facebook, ² Instagram, ³ Reddit, ⁴ and YouTube ⁵ offer broad audience engagement, while health-specific forums such as WebMD ⁶ as well as Q&A platforms such as Quora ⁷ and Ask a Patient ⁸ focus on medical discussions. Additionally, other platforms such as the e-commerce site Amazon ⁹ and various blogs have user reviews and discussions on drug products, enriching the data pool for drug safety analysis. Collectively, these social media platforms offer data that can facilitate a comprehensive understanding of patient experiences, medication effects, and healthcare trends.

Social media platforms differ in data scale, user demographics, content modality, and real-time accessibility—factors that shape their utilization in pharmacovigilance. X features high-frequency, short-text updates in real time, making it well-suited for detecting emerging safety signals, particularly among its predominantly young U.S. users. Facebook provides large-scale, globally diverse user demographics and facilitates lifestyle sharing, intergenerational interaction, and marketplace activity. Instagram contains visually rich content—photos and videos—primarily around themes like fashion, beauty, and travel, attracting a younger audience but offering limited textual data. Reddit hosts in-depth, community-driven discussions on topics such as technology and health through anonymous forums, though it lacks real-time immediacy. YouTube delivers both long- and short-form video content across educational and entertainment topics to a global, multi-generational audience, but pharmacovigilance efforts on the platform require resource-intensive video analysis. Health forums focus on structured, medically-oriented discussions within smaller, specialized communities. E-commerce platforms like Amazon provide valuable insight into over-the-counter medication safety through consumer reviews. Meanwhile, blogs and online surveys, though useful for exploring historical public opinion, are declining in relevance compared to more dynamic and interactive social media channels. These variations highlight the importance of tailoring pharmacovigilance strategies to each platform—leveraging the strengths of real-time surveillance on X or visual content on Instagram, while accounting for constraints in scalability, content richness, or demographic coverage.

Social media has evolved significantly since its early days in the 1970s, when online communication was limited to basic chat rooms and forums. In the 2000s, platforms such as Facebook, X (formerly Twitter), and Instagram emerged, enabling users to share experiences in real time. Over time, social media content has expanded from text-based posts to multimedia formats, including images, videos, and live interactions. Access for researchers has also changed—while many platforms initially offered open APIs for data analysis, recent restrictions have limited the availability of user-generated content, posing new challenges for social media-based research. Researchers are employing adaptive strategies such as web scraping, synthetic data generation, and collaborative research agreements with platforms to obtain unrestricted access to social media data for pharmacovigilance research, thereby mitigating the challenges posed by recent API limitations. Table 1 summarizes popular social media platforms and drug safety studies based on data extracted from these platforms.

X has emerged as a pivotal resource in pharmacovigilance, providing insight into public perceptions and experiences regarding medications. Researchers have effectively leveraged this platform to extract valuable information, including adverse drug events, user sentiments, and discussions on drug safety and efficacy. Through the application of analytical methods such as natural language processing, machine learning, and sentiment analysis, they have managed the challenges posed by extensive data volumes and noise in the user-generated content, thereby enhancing drug safety monitoring and public health strategies. For instance, Sule et al. [1] utilized X to combat the dissemination of COVID-19 misinformation from physicians, thereby contributing to the improvement of public health communications. Pathak and Catalan-Matamoros [2] explored X’s potential as an early warning system for drug safety signals, with the aim of strengthening pharmacovigilance practices. Hua et al. [8] investigated public perceptions of COVID-19-related medications using X, offering valuable insight for pharmacovigilance and policy-making decisions. Sharma et al. [11] conducted a scoping review utilizing sentiment analysis to comprehend patient experiences with pharmacotherapy. Rezaei et al. [12] applied deep learning techniques to detect adverse drug events on X, thereby enhancing the efficiency of safety concern identification. Lardon et al. [23] evaluated X as a supplementary data source for pharmacovigilance and compared it with traditional monitoring systems. Khademi et al. [32] developed a model by coupling topic modeling and transformer-based learning for the early detection of vaccine safety signals in X posts, and the detected adverse events were generally aligned with those reported in a spontaneous vaccine safety surveillance system, showcasing the potential of social media data for early detection of emerging vaccine safety issues. These examples underscore the versatility and value of X posts in complementing traditional pharmacovigilance methods, particularly during public health crises like the COVID-19 pandemic, and in understanding off-label medication use.

Facebook offers important user-generated data for pharmacovigilance, covering discussions, comments, and posts on medications, adverse drug reactions, and drug safety feelings. This data helps improve post-marketing drug safety surveillance. For example, Pierce et al. [26] explored the possibility of detecting drug adverse events in Facebook and X earlier than their reports in the FDA Adverse Event Reporting System (FAERS), demonstrating that social media platforms such as Facebook and X can be used for early detection of certain adverse events. Powell et al. [28] investigated the usefulness of Facebook in post-marketing drug safety surveillance by examining its effectiveness in capturing patient experiences and concerns on medications, indicating that Facebook provides data for the detection of early warning signs of potential drug safety. Coloma et al. [29] used Facebook in their evaluation of social media networks' contributions to drug safety surveillance, demonstrating the usefulness of the patient-reported information in pharmacovigilance. These studies collectively highlight the significant role of Facebook in pharmacovigilance, supporting better regulatory decisions and patient care.

Instagram, a popular social media platform owned by Facebook, Meta, allows users to share photos, videos, and engage with others through likes, comments, and direct messaging. For instance, Li et al. [48] focused on developing a machine learning approach for identifying and profiling illicit drug dealers on Instagram by analyzing posts and comments for hashtags and language patterns associated with illegal drug dealings. Through an examination of posts and comments, this study identified key information like hashtags and language patterns indicative of illegal drug activities. This research addresses concerns about drug sales on social media and suggests a mechanism that may help counteract such occurrences.

Reddit’s diverse communities offer a wealth of user-generated health data, making it a valuable platform for pharmacovigilance and public health research. For instance, Godinez et al. [51] analyzed Reddit discussions to gain an understanding of the experiences and concerns of individuals transitioning between HIV pre-exposure prophylaxis medications, thereby informing healthcare policies. Guo et al. [50] utilized the Reddit platform for real-time tracking and analysis of COVID-19 symptoms, facilitating early detection and response to the pandemic. Furthermore, Szczypka et al. [55] explored Reddit discussions on Delta-8-tetrahydrocannabinol, shedding light on public perceptions and potential health risks associated with its use. Lastly, Sharp et al. [53] conducted a comprehensive analysis of 11 years of Reddit posts related to dietary supplements among military personnel, providing valuable data on safety, efficacy, and usage patterns within this specific population. These examples collectively underscore the significant role of Reddit in enhancing our understanding of drug safety and informing public health strategies.

YouTube, being a widely utilized video-sharing platform, provides a rich source of information on medication usage and health-related topics. For example, Hansen et al. [56] assessed the accuracy of safety information conveyed in YouTube videos about medication usage during pregnancy. Their aim was to ensure that pregnant women have access to reliable and evidence-based guidance to facilitate informed decision-making for their well-being.

Research on drug safety is increasingly leveraging patient-generated data from health-specific forums and online consultation platforms, such as WebMD. These studies utilize quantitative analysis and natural language processing techniques to extract information directly from patient reviews and discussions, providing a unique perspective on medication adherence, adverse drug reactions, and patient satisfaction. By comparing patient-reported reasons for medication changes against formal adverse event reporting systems and assessing the cognitive levels and intervention preferences of patients with hypertriglyceridemia, these research efforts enhance our understanding of real-world medication experiences and safety concerns, ultimately contributing to the improvement of pharmacovigilance practices.

In addition to WebMD, numerous health forums cater to different languages and focus on various topics. For instance, Abdellaoui et al. [77] used a topic modeling approach to identify instances of noncompliance to drug treatment in patient forum posts. Similarly, Karapetiantz et al. [78] found a discrepancy between personal experiences and negative opinions with the human papillomavirus vaccine in web forums. They also found that descriptions of adverse drug reactions are less detailed in forums compared to the French Pharmacovigilance Database, ¹⁰ however, forums provide more unexpected reactions [79]. These examples illustrate the potential of health-specific forums and online consultation platforms in enhancing our understanding of drug safety and improving pharmacovigilance practices. They emphasize the importance of considering patient experiences and perspectives in different languages and contexts. Such an approach not only enriches available data for analysis but also ensures a more comprehensive and inclusive understanding of drug safety.

Q&A platforms like Quora and patient feedback websites such as ⁸ play a crucial role in drug safety research by providing a space for patients to share their experiences, ask questions about medications, and discuss their treatment preferences. For instance, Xu et al. [61] analyzed the discussions about COVID-19 vaccine clinical trials on Quora, providing insight into public sentiment and common questions about the trials, which can inform future communication strategies and patient education efforts. Similarly, Song et al. [62] conducted a social media listening infosurveillance study to evaluate the needs and experiences of patients with hypertriglyceridemia. They identified common concerns and preferences that can be utilized to guide the development of patient-centered care strategies for this population. Moreover, Duh et al. [63] explored whether social media data could aid in the early detection of drug-related adverse events. They found that patient discussions on platforms like ⁸ can provide early warning signs of potential adverse events, thereby enhancing the timeliness and effectiveness of pharmacovigilance efforts. These examples underscore the potential of Q&A platforms and patient feedback websites in drug safety research, emphasizing the importance of incorporating patient voices in the study to improve drug safety practices.

E-commerce platforms like Amazon serve as valuable repositories of consumer-generated data for drug safety research. By examining user reviews, ratings, and Q&A sections, researchers can gain insight into the real-world performance and safety of over-the-counter medications and health products. For instance, Adams et al. [64] used an automated method to uncover safety and efficacy issues related to joint and muscle pain treatments from Amazon reviews. Similarly, Gartland et al. [65] focused on creating crowdsourced training datasets for pharmacovigilance intelligent automation, illustrating the potential of platforms like Amazon Turk to provide valuable data for training machine learning models in pharmacovigilance studies. These examples highlight the significance of e-commerce platforms in drug safety research, enhancing our understanding of medication safety and efficacy in real-world contexts.

In the past, news articles and blog posts were frequently used as primary data sources for drug safety research. However, their utilization has witnessed a decline in recent years. Despite the shift from blogs to real time social media platforms, traditional news and blog data can still yield valuable insights for drug safety research. For example, de Vries et al. [66] analyzed a series of healthcare provider communications in newspaper articles spanning from 2001 to 2015 in the Netherlands, demonstrating the value of such media in drug safety research. Similarly, Matsuda et al. [68] analyzed patient narratives sourced from disease-specific blogs, a component of the TOBYO database, ¹¹ revealing valuable real-world medication experiences and emphasizing the potential of such platforms in bolstering drug safety research and pharmacovigilance efforts. These examples emphasize the significant role of news and blog data in understanding public perceptions and experiences related to drug safety.

Online surveys are valuable tools in drug safety research, providing a platform for collecting large-scale patient-generated data. For instance, Grundmann et al. [70] used an online survey to investigate patterns of Kratom use and its health impact in the US. Similarly, Wysota et al. [75] and Nguyen et al. [76] utilized online surveys to understand consumers’ knowledge, perceptions, and usage of cannabidiol products. The widespread adoption of online surveys signifies their pivotal role in advancing drug safety research by providing a robust platform for data collection and analysis.

In the realm of pharmacovigilance, social media has emerged as a pivotal source of information, offering unprecedented access to a wealth of data regarding patient experiences, perceptions, and discussions related to medication use and safety. This section delves into the various ways social media data can be harnessed to enhance our understanding of patient experiences, detect and analyze adverse drug events, assess vaccine efficacy and safety, and combat the spread of misinformation. It highlights the importance of leveraging social media platforms to inform healthcare practices, improve pharmacovigilance efforts, and address the challenges posed by misinformation, ultimately aiming to enhance public health and safety. Table 2 shows the categories of key information extracted from social media.

The integration of social media data into drug safety monitoring has significantly advanced the detection of adverse drug events, analysis of public sentiment, monitoring of drug abuse, and identification of drug-drug interactions. Social media platforms, with their vast and diverse user-generated content, offer a unique perspective on real-world patient experiences and public perceptions of medications.

In adverse drug events detection, both supervised and unsupervised learning methods, including models like BERT and co-clustering algorithms, are applied to extract and analyze adverse events from social media posts. For public sentiment analysis, cutting-edge sentiment analysis models are being used to assess patient feedback and identify potential safety signals. Meanwhile, drug abuse monitoring employs large language models and quantitative analysis to detect trends in misuse, addiction, and overdose incidents. The identification of drug-drug interactions is enhanced through network analysis and supervised learning techniques.

These methods are reshaping pharmacovigilance, enabling faster identification of safety concerns, a deeper understanding of patient experiences, and more effective monitoring of public health issues. Table 3 summarizes the various methods and their applications in utilizing social media data to advance drug safety studies.

Integrating social media data into drug safety research offers valuable insight, but presents several challenges that must be addressed to ensure reliable and actionable findings.

The integration of social media data into drug safety research offers promising opportunities to enhance pharmacovigilance. Social media’s vast, real-time data can complement traditional methods, enabling early detection of adverse drug events, monitoring public sentiment, and capturing patient experiences on medication risks and benefits. However, unlocking the full potential of social media in drug safety research requires addressing significant methodological, ethical, and regulatory challenges.

This review highlights the need for rigorous methodologies, including advanced data validation, standardized data processing protocols, and specialized text mining models tailored to the unique characteristics of social media content. Ethical considerations, such as privacy protection and transparent practices, are essential to maintaining public trust. Additionally, as social media evolves, developing a strong regulatory framework to govern the use of social media data in pharmacovigilance is important.

Future research should focus on developing real-time monitoring systems that can utilize social media for the early detection of drug safety concerns. Hybrid models that integrate social media data with traditional pharmacovigilance data hold promise for the potential to improve the accuracy, speed, and scope of safety signal detection. Standardizing data collection and analytical methodologies across studies will enhance consistency and reliability, enabling more actionable findings. Addressing cultural and linguistic diversity in social media content will also be essential to adapt these approaches to global pharmacovigilance efforts.

Collaboration among academia, industry, regulatory agencies, and social media platforms will play a key role in advancing these goals. Such partnerships can foster resource sharing, methodological alignment, and innovation in drug safety monitoring. Regulatory agencies can provide guidance on ethical and privacy standards, while social media platforms can facilitate data access and support anonymization efforts. These collaborative efforts will help establish a robust and responsive pharmacovigilance ecosystem, enhancing post-market surveillance and protecting public health worldwide. By integrating social media data with established pharmacovigilance practices, researchers and healthcare providers can improve post-marketing drug safety monitoring, enhance public health outcomes, and build a collaborative ecosystem that benefits patients and society.